Who Paid My Doc
Angelica Jimenez
Geriatric Medicine Hollywood, FL Medical Doctor
NPI 1013012566 CMS profile 272607
1150 N 35Th Ave, Suite 135, Hollywood, FL 33021
General payments
$1,879
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Angelica Jimenez of Hollywood, FL is reported in the CMS Open Payments database as having received $1,879 across 14 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 85th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $1,403 | 1 | |
| 2023 | General | $26 | 1 | |
| 2019 | General | $450 | 12 |
Beside peers
- Angelica Jimenez
- Geriatric Medicine median
- Middle half of Geriatric Medicine
- National median
In program year 2025, general payments to Angelica Jimenez were reported at $0. Among 512 Geriatric Medicine profiles paid that year, the median was $120 and the middle half received between $37 and $350.
Show as a table
| Year | Angelica Jimenez | Geriatric Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $450 | $96 | $28–$339 | $163 |
| 2020 | $0 | $99 | $28–$262 | $114 |
| 2021 | $0 | $94 | $27–$318 | $132 |
| 2022 | $0 | $103 | $34–$338 | $149 |
| 2023 | $26 | $109 | $39–$320 | $160 |
| 2024 | $1,403 | $125 | $36–$371 | $164 |
| 2025 | $0 | $120 | $37–$350 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 4 billing codesPaid by Medicare
$8,970
Medicare patients
61
Services billed
104
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 70% | |
| Heart failure | 66% | |
| Ischemic heart disease | 59% | |
| Depression | 59% | |
| Chronic kidney disease | 56% | |
| COPD | 56% | |
| Alzheimer's or dementia | 52% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
14 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Geriatric Medicine in Florida
Malcolm Fraser
Geriatric Medicine · Brooksville, FL
Valeria Baldivieso Hurtado
Geriatric Medicine · Winter Park, FL
Kashan Khan
Geriatric Medicine · Kissimmee, FL
Charina Yango Cadavos
Geriatric Medicine · Naples, FL
Venkatreddy Alugubelli
Geriatric Medicine · Beverly Hills, FL
Anthony Alatriste
Geriatric Medicine · Ocoee, FL
Related records
Geriatric Medicine in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Geriatric Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.